 ,Screening, ,Placebo-Controlled,Phase, , ,Apremilast,Extension,Phaseb,Post-Treatment Observational Follow-upd
Visit Number,1,Baseline 2,3,4,5,6,7,8,9/ETÂ°, 
Week,-35 to 0 days,0 (Day 1),2 ( 3 days),4 ( 3 days),16 ( 3 days),20 (= 4 days),32 ( 4 days),44 ( 4 days),52 (= 4 days),56 weeks (or 4 weeks after study discontinuation)
Informed consente,SELECTED X,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,-
Inclusion/Exclusion criteria,SELECTED X,SELECTED X,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,-
Demographics,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,NOT_SELECTED -,-
Medical history,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,-
Prior / concomitant medications or therapies,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -
Clinical and Laboratory,Assessments, , , , , , , , ,NOT_SELECTED
Adverse events,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X
Pregnancy test and contraception education,SELECTED X,SELECTED X,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,NOT_SELECTED -,SELECTED X,NOT_SELECTED -
Vital signs,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -
Height,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,NOT_SELECTED -
Weight,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -
Waist Circumference,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
Body Mass Index,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,-
Physical Examination,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,-
"Clinical laboratory evaluations-h,",SELECTED X,SELECTED X,NOT_SELECTED -,NOT_SELECTED -,SELECTED X,NOT_SELECTED -,SELECTED X,NOT_SELECTED -,SELECTED X,-
Health-related Quality of,Life and,Efficacy Assessments, , , , , , , , 
DLQI,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
sPGA of Visible Location,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -,SELECTED X,-
ScPGAk,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -,SELECTED X,-
Nail Assessment,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -,SELECTED X,-
NAPSI,NOT_SELECTED,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -,SELECTED X,-
Modified sPGA-Gk,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,NOT_SELECTED -
PPPGAK,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,NOT_SELECTED -
Itch NRS,NOT_SELECTED -,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
Skin Discomfort/Pain VAS,SELECTED -,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
PASI,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
BSA,SELECTED -,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED -,SELECTED X,-
EQ-5D,SELECTED -,SELECTED X,SELECTED -,NOT_SELECTED -,SELECTED X,NOT_SELECTED -,SELECTED -,SELECTED -,SELECTED X,-
PNQ,SELECTED -,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,SELECTED -,NOT_SELECTED -,-
PBQ,SELECTED -,SELECTED -,SELECTED -,SELECTED X,SELECTED X,SELECTED -,SELECTED X,SELECTED -,SELECTED X,-
WPAI: PSO,SELECTED -,SELECTED X,SELECTED -,NOT_SELECTED -,SELECTED X,SELECTED -,SELECTED -,SELECTED -,SELECTED X,-
"Photography""",SELECTED -,SELECTED X,SELECTED -,NOT_SELECTED -,SELECTED X,NOT_SELECTED -,SELECTED X,SELECTED -,SELECTED X,-
Dispense IP,NOT_SELECTED -,SELECTED X,NOT_SELECTED -,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -,NOT_SELECTED -
Return and Count IP Tablets,NOT_SELECTED -,NOT_SELECTED -,SELECTED -,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED -
